Pro-epileptic effects of the cannabinoid receptor antagonist SR141716 in a model of audiogenic epilepsy

Epilepsy Research

Volumn 96, Issue 3, 2011, Pages 250-256

  Vinogradova, Lyudmila V ^a   Shatskova, Alla B ^a   Van Rijn, Clementina M ^b  

^a INSTITUTE OF HIGHER NERVOUS ACTIVITY AND NEUROPHYSIOLOGY   (Russian Federation)

^b RADBOUD UNIVERSITY   (Netherlands)

Author keywords

Audiogenic seizure; CB1 receptors; Endocannabinoid system; Epilepsy; SR141716 (rimonabant)

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR ANTAGONIST; RIMONABANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; AUDIOGENIC SEIZURE; AUDITORY STIMULATION; BRAIN STEM SEIZURE; CLONUS; CONTROLLED STUDY; DRUG EFFECT; DRUG TARGETING; FOREBRAIN; KINDLING; LIMBIC SYSTEM; LONG TERM CARE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPEATED DRUG DOSE; RUNNING; SEIZURE; WISTAR RAT;

ACOUSTIC STIMULATION; ACUTE DISEASE; ANIMALS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSY, REFLEX; KINDLING, NEUROLOGIC; LIMBIC SYSTEM; MALE; PIPERIDINES; PYRAZOLES; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; SEIZURES;

EID: 80053917610     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2011.06.007     Document Type: Article

References (38)

1. Alger B.E. Endocannabinoids and their implication for epilepsy. Epilepsy Cur. 2004, 4:169-173.
2. Araujo B.H.S., Torres L.B., Cossa A.C., Naffah-Mazzacoratti M.G., Cavalheiro E.A. Hippocampal expression and distribution of CB1 receptors in the Amazonian rodent Proechimys: an animal model of resistance to epilepsy. Brain Res. 2010, 1335:35-40.
3. Bidaut-Russell M., Devane W.A., Howelett A.C. Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain. J. Neurochem. 1990, 55:21-26.
4. Bhaskaran M.D., Smith B.N. Cannabinoid-mediated inhibition of recurrent excitatory circuitry in the dentate gyrus in a mouse model of temporal lobe epilepsy. PLoS One 2010, 5:e10683.
5. Braakman H.M.H., Van Oostenbrugge R.J., Van Kranen-Mastenbroek V.H.J.M., De Krom M.C.T.F.M. Rimonabant induces partial seizures in a patient with a history of generalized epilepsy. Epilepsia 2009, 50:2171-2172.
6. Bragin A., Wilson C.L., Engel J. Increased afterdischarge threshold during kindling in epileptic rats. Exp. Brain Res. 2002, 144:30-37.
7. Browning R.A. Neuroanatomical localization of structures responsible for seizures in the GEPR: lesion studies. Life Sci. 1986, 39:857-867.
8. Chen K., Neu A., Howard A.L., Foldy C., Echegoyen J., Hilgenberg L., Smith M., Mackie K., Soltesz I. Prevention of plasticity of endocannabiniod signaling inhibits persistent limbic hyperexcitability caused by developmental seizures. J. Neurosci. 2007, 27:46-58.
9. Deransart C., Le-Pham B.-T., Hirsch E., Marescaux C., Depaulis A. Inhibition of substantia nigra suppresses absences and clonic seizures in audiogenic rats, but not tonic seizures: evidence for seizure specificity of the nigral control. Neuroscience 2001, 105:203-211.
10. Dudek F.E., Pouliot W.A., Rossi C.A., Staley K.J. The effect of the cannabinoid-receptor antagonist, SR 141716, on the early stage of kainate-induced epileptogenesis in the adult rat. Epilepsia 2010, 51(Suppl. 3):126-130.
11. Echegoyen J., Armstrong C., Morgan R.J., Soltesz I. Single application of a CB1 receptor antagonist rapidly following head injury prevents long-term hyperexcitability in a rat model. Epilepsy Res. 2009, 85:123-127.
12. Faingold C.L. Role of GABA abnormalities in the inferior colliculus pathophysiology-audiogenic seizures. Hear. Res. 2002, 168:223-237.
13. Falenski K.W., Carter D.S., Harrison A.J., Martin B.R., Blair R.E., DeLorenzo R.J. Temporal characterization of changes in hippocampal cannabinoid CB1 receptor expression following pilocarpine-induced status epilepticus. Brain Res. 2009, 1262:64-72.
14. Galvis-Alonso O.Y., Cortes de Oliveira J.A., Garcia-Cairasco N. Limbic epileptogenicity, cell loss and axonal reorganization induced by audiogenic and amygdala kindling in Wistar audiogenic rats (WAR strain). Neuroscience 2004, 125:787-802.
15. Goffin K., Van Paesschen W., Van Laere K. In vivo activation of endocannabinoid system in temporal lobe epilepsy with hippocampal sclerosis. Brain 2011, 134:1033-1040.
16. Guggenhuber S., Monory K., Lutz B., Klugmann M. AAV vector-mediated overexpression of CB1 cannabinoid receptor in pyramidal neurons of the hippocampus protects against seizure-induced excitotoxicity. PLoS One 2010, 5:e15707. (1-8).
17. Lado F.A., Moshe S.L. How do seizures stop?. Epilepsia 2008, 49:1651-1664.
18. Loscher W., Kohling R. Functional, metabolic and synaptic changes after seizures as potential targets for antiepileptic therapy. Epilepsy Behav. 2010, 19:105-113.
19. Lutz B. On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures. Biochem. Pharmacol. 2004, 68:1691-1698.
20. Ludanyi A., Eross L., Czirjak S., Vaida J., Halasz P., Watanabe M., Palkowits M., Magloczky Z., Freund T.F., Katona I. Downregulation of the CB1 cannabinoid receptor and related molecular elements of the endocannabiniod system in epileptic human hippocampus. J. Neurosci. 2008, 28:2976-2990.
21. Merrill M.A., Clough R.W., Jobe P.J., Browning R.A. Brainstem seizure severity regulates forebrain seizure expression in the audiogenic kindling model. Epilepsia 2005, 46:1380-1388.
22. Monory K., Massa F., Egertova M., Eder M., Blaudzun H., Westernbroek R., Kelsch W., Jacob W., Marsch R., Ekker M., Long J., Rubenstein J.L., Goebbels S., Nave K.A., During M., Klugmann M., Wolfel B., Dodt H.U., Zeiglgansberger W., Wotjak C.T., Mackie K., Elphick M.R., Marsiano G., Lutz B. The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 2006, 51:455-466.
23. Mucha R.F., Pinel F.J. Postseizure inhibition of kindled seizures. Exp. Neurol. 1977, 54:266-282.
24. Naritoku D.K., Mecozzi L.B., Aiello M.T., Faingold C.L. Repetition of audiogenic seizures in genetically epilepsy-prone rats induces cortical epileptiform activity and additional seizure behaviors. Exp. Neurol. 1992, 115:317-324.
25. Pitkanen A. Therapeutic approaches to epileptogenesis-Hope on horizon. Epilepsia 2010, 51(Suppl. 3):2-17.
26. Post R.M., Putnam F., Contel N.R., Goldman B. Electroconvulsive seizures inhibit amygdala kindling: implications for mechanisms of action in affective illness. Epilepsia 1984, 25:234-239.
27. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. EEG Clin. Neurophysiol. 1972, 32:281-294.
28. Semyanov A., Morenkov E., Godukhin O. The decreased susceptibility to the development of in vitro kindling-like state in hippocampal CA1 slices of rats sensitive to audiogenic seizures. Neurosci. Lett. 1997, 230:187-190.
29. Simler S., Vergnes M., Marescaux C. Spatial and temporal relationships between c-fos expression and kindling of audiogenic seizures in Wistar rats. Exp. Neurol. 1999, 157:106-119.
30. Tsou K., Brown S., Sanudo-Pena M.C., Mackie K., Walker J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 1998, 83:393-411.
31. Tupal S., Faingold C.L. Precipitous induction of audiogenic kindling by activation of adenylyl cyclase in the amygdala. Epilepsia 2010, 51:354-361.
32. Van Rijn C.M., Gaetani S., Santolini I., Badura A., Gabova A., Fu J., Watanabe M., Cuomo V., van Luijtelaar G., Nicoletti F., Ngomba R.T. WAG/Rij rats show a reduced expression of CB1 receptors in thalamic nuclei and respond to the CB1 receptor agonist, R(+)WIN55,212-2 with a reduced incidence of spike-wave discharges. Epilepsia 2010, 51:1511-1521.
33. Van Rijn C.M., Perescis M.F.J., Vinogradova L., van Luijtelaar G. The endocannabinoid system protects against cryptogenic seizures. Pharmacol. Rep. 2011, 63:165-168.
34. Vinogradova L.V. Audiogenic kindling in Wistar and WAG/Rij rats: kindling-prone and kindling-resistant subpopulations. Epilepsia 2008, 49:1665-1674.
35. Vinogradova L.V., van Rijn C.M. Anticonvulsive and antiepileptogenic effects of levetiracetam in the audiogenic kindling model. Epilepsia 2008, 49:1160-1168.
36. Vinogradova L.V., Kuznetsova G.D., Shatskova A.B., van Rijn C.M. Vigabatrin in low doses selectively suppresses the clonic component of audiogenically kindled seizures in rats. Epilepsia 2005, 46:800-810.
37. Wallace M.J., Blair R.E., Falenski K.W., Martic B.R., DeLorenzo R.J. The endogeneous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. J. Pharmacol. Exp. Ther. 2003, 307:129-137.
38. Zhao Y., Rubio M.E., Tzounopoulos T. Distinct functional and anatomical architecture of the endocannabinoid system in the auditory brainstem. J. Neurophysiol. 2009, 101:2434-2446.